Abstracts tagged "psoriatic arthritis and spondylarthropathy"

Abstract Number: 1356 • 2012 ACR/ARHP Annual Meeting
Gender Differences Among Spondylitis Associated with Psoriasis, Inflammatory Bowel Disease and Primary Ankylosing Spondylitis
Margarita Landi¹, Hernan Maldonado-Ficco², Jose A. Maldonado-Cocco², Gustavo Citera³, Pablo Arturi², Percival Sampaio-Barros⁴, Diana Flores⁵, Ruben Burgos-Vargas⁶, Helena Santos⁷, Jose Chavez-Corrales⁸, Daniel Palleiro⁹, Miguel A. Gutierrez¹⁰, Elsa Vieira-Sousa¹¹, Fernando Pimentel-Santos¹², Sergio O. Paira¹³, Alberto Berman Sr.¹⁴, Janitzia Vazquez-Mellado¹⁵, Eduardo Collantes-Estevez¹⁶ and On behalf of RESPONDIA Group¹⁷, ¹Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina, ²Rheumatology, Instituto de Rehabilitacion Psicofisica and Fundacion Reumatologica Argentina, Buenos Aires, Argentina, ³Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁴Rheumatology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil, ⁵Rheumatology, Hospital Universitario, Monterrey, Mexico, ⁶Rheumatology, Hospital General de Mexico, Mexico DF, Mexico, ⁷Rheumatology, Instituto Português de Reumatologia, Lisboa, Portugal, ⁸Rheumatology, Hospital Nacional E. Rebagliti-ESSALUD, Lima, Peru, ⁹Rheumatology, Instituto Nacional de Reumatologia, Montevideo, Uruguay, ¹⁰Rheumatology and Inmunology, Pontificia Universidad Catolica de Chile, Santiago, Chile, ¹¹Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, ¹²Rheumatology, Centro Hospitalar de Lisboa Ocidental, Hospital Egas Moniz, Lisboa, Portugal, ¹³Hospital Jose María Cullen, Santa Fe SFE S3000BFP, Argentina, ¹⁴Internal Medicine, Hospital Padilla, Tucuman, Argentina, ¹⁵Rheumatology, Hospital General de Mexico, Mexico city, Mexico, ¹⁶Depatamento de Medicina, IMIBIC-Reina Sofia Hospital, Cordoba 14012, Spain, ¹⁷Buenos Aires
Background/Purpose: Differences regarding gender in primary Ankylosing Spondylitis are well known. However, there is less evidence regarding Spondylitis Associated with Psoriasis and that associated with…
Abstract Number: 1360 • 2012 ACR/ARHP Annual Meeting
Spinal Involvement in Axial Psoriatic Artritis Is Not Determined by the Presence of HLA-B27. Is the HLA-B27 Arm of the Axial Spa Criteria Reliable for Classifying Axial Psoriatic Arthritis?
Jose Luis Fernandez-Sueiro¹, JA Pinto¹, S. Pertega-Diaz², E. Gonzalez³, Ignacio Rego-Perez⁴, Francisco J. de Toro-Santos⁵ and Francisco J. Blanco V⁶, ¹Rheumatology Division, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, ²Epidemiology and Statistics, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, ³Rheumatology, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, ⁴INIBIC-Hospital Universitario A Coruña. Genomic Group. Rheumatology Division., A Coruña, Spain, ⁵Reumatology, Complejo Hospitalario Universitario Juan Canalejo, Universidad de la Coruña, La Coruña, Spain, ⁶Rheumatology Service, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain
Background/Purpose: There is a debate whether axial psoriatic arthritis (axPsA) is an ankylosing spondylitis with psoriasis, however due to the fact that PsA has characteristic…
Abstract Number: 1026 • 2012 ACR/ARHP Annual Meeting
Psoriatic Arthritis and Spondyloarthritis: Inflammation Assessed by “Head to Toe” Wholebody Magnetic Resonance Imaging – A Comparison with Clinical Joint Examination
René Panduro Poggenborg¹, Susanne Juhl Pedersen², Iris Eshed³, Inge Juul Sørensen⁴, Ole Rintek Madsen⁵, J.M. Møller⁶ and Mikkel Østergaard⁷, ¹Department of Rheumatology, Copenhagen University Hospital in Glostrup, Copenhagen, Denmark, ²Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, ³Department of Radiology, Sheba Medical Center, Tel Hashomer, Israel, ⁴Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, ⁵Department of Rheumatology, Copenhagen University Hospital in Gentofte, Copenhagen, Denmark, ⁶Department of Radiology, Copenhagen University Hospital in Herlev, Copenhagen, Denmark, ⁷Copenhagen University Hospital Glostrup, Glostrup, Denmark
Background/Purpose: Psoriatic arthritis (PsA) and spondyloarthritis (SpA) is associated with a varied pattern of axial and peripheral inflammation. Wholebody magnetic resonance imaging (WBMRI) is a…
Abstract Number: 596 • 2012 ACR/ARHP Annual Meeting
Evolution of Atherosclerosis in Psoriatic Arthritis: Is the Former an Independent Inflammatory Process?
Roberta Ramonda¹, Massimo Puato², Valentina Modesti³, Mariagrazia Lorenzin⁴, Paola Frallonardo⁴, Augusta Ortolan⁴, Carla Campana³, Alessandro Lo Nigro³ and Leonardo Punzi⁵, ¹Rheumatology Unit, University of Padova, Padova, Italy, ²Department of Internal Medicine, University of Padova, Padova, Italy, ³Unit of Rheumatology, University of Padova, Padova, Italy, ⁴Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy, ⁵Clinical and Experimental Medicine, Rheumatology Unit - University of Padova, Padova, Italy
Background/Purpose: A non-invasive study focusing on the structural and functional properties of the carotid arteries was carried out in psoriatic arthritis (PsA) patients. Increased cardiovascular…
Abstract Number: 579 • 2012 ACR/ARHP Annual Meeting
Prevalence of Psoriatic Arthritis in Psoriasis Patients According to Newer Classification Criteria
Hernan Maldonado-Ficco¹, Gustavo Citera¹, Ana Alba Porrini² and Jose A. Maldonado-Cocco¹, ¹Rheumatology, Instituto de Rehabilitacion Psicofisica - Fundacion Reumatologica Argentina Dr. Osvaldo Garcia-Morteo, Buenos Aires, Argentina, ²Rheumatology, Hospital Argerich, Buenos Aires, Argentina
Background/Purpose: To determine the prevalence of Psoriatic Arthritis (PsA) in a cohort of psoriasis patients according to CASPAR criteria, and compare it with that resulting from…
Abstract Number: L4 • 2012 ACR/ARHP Annual Meeting
Continued Improvement of Signs and Symptoms in Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
Arthur Kavanaugh¹, Iain B. McInnes², Alice B. Gottlieb³, Lluis Puig⁴, Proton Rahman⁵, Christopher T. Ritchlin⁶, Shu Li⁷, Yuhua Wang⁷, Mittie K. Doyle⁸ and Alan M. Mendelsohn⁹, ¹UCSD School of Medicine, La Jolla, CA, ²University of Glasgow, Glasgow, Scotland, ³Tufts Medical Center, Boston, MA, ⁴Universitat Autònoma de Barcelona, Barcelona, Spain, ⁵Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, ⁶Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, ⁷Janssen Research & Development, LLC., Spring House, PA, ⁸Janssen Research & Development, LLC, Spring House, PA, ⁹Immunology, Janssen Research & Development, LLC., Spring House, PA
Background/Purpose: PSUMMIT I ,through wk24, demonstrated efficacy and safety of ustekinumab (UST) in reducing signs and symptoms of active psoriatic arthritis (PsA) in a large,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].